Suppr超能文献

在急性缺血性中风患者中,t-PA治疗后1至24小时内再通是脑出血的有力预测指标。

Recanalization between 1 and 24 hours after t-PA therapy is a strong predictor of cerebral hemorrhage in acute ischemic stroke patients.

作者信息

Kimura Kazumi, Iguchi Yasuyuki, Shibazaki Kensaku, Kobayashi Kazuto, Uemura Junichi, Aoki Junya, Yamashita Shinji, Terasawa Yuka, Matsumoto Noriko

机构信息

Department of Stroke Medicine, Kawasaki Medical School, Japan.

出版信息

J Neurol Sci. 2008 Jul 15;270(1-2):48-52. doi: 10.1016/j.jns.2008.01.013. Epub 2008 Mar 4.

Abstract

BACKGROUND AND PURPOSE

Intravenous administration of tissue plasminogen activator (t-PA) can improve clinical outcomes in patients with acute ischemic stroke. The most important complication of t-PA therapy is intracerebral hemorrhage (ICH). The aim of this study was to use serial MRI studies to identify independent predictors of symptomatic and asymptomatic ICH after t-PA therapy.

METHODS

Consecutive anterior-circulation ischemic stroke patients treated with t-PA within 3 h of stroke onset were studied prospectively. To identify the presence of recanalization in the occluded arteries and the presence of ICH, MRI, including diffusion weighted imaging (DWI), T2*, and magnetic resonance angiography (MRA), was performed before and 1 h, 24 h, and 5-7 days after t-PA thrombolysis. The independent predictors of ICH were determined using multivariate logistic regression analysis.

RESULTS

41 patients (21 males, 20 females; mean age, 73.2+/-10.7 years) were enrolled, and 19 ICHs (1 symptomatic, 18 asymptomatic) were observed on T2*. The initial MRA demonstrated occluded brain arteries in 31 patients (75.6%), of which follow-up MRA at 1 h, 24 h, and 5-7 days after t-PA therapy revealed recanalization in 48.4%, 80.0%, and 90.0% of patients, respectively. The frequency of recanalization within 1 h after t-PA therapy did not differ between ICH and No-ICH groups, but the ICH group had more frequent recanalization between 1 h and 24 h after t-PA than the No-ICH group (50.0% vs. 4.5%, P=0.001). The ICH group had arterial fibrillation (AF) more frequently than the No-ICH group (78.9% vs. 27.3%, P=0.001). Compared to the No-ICH group, the NIHSS score was higher (16.4+/-5.7 vs. 11.5+/-6.5, P=0.011) and the ASPECTS-DWI value (a normal DWI has an ASPECTS-DWI value of 11 points) was lower (7.3+/-2.4 vs. 8.9+/-1.9, P=0.019) in the ICH group. Multivariate logistic regression analysis demonstrated that the presence of recanalization between 1 and 24 h after the end of t-PA infusion (OR: 20.2; CI: 1.0-340.9; P=0.037) was the only independent predictor of ICH.

CONCLUSION

Recanalization of occluded arteries between 1 and 24 h but not within 1 h after t-PA infusion should be independently associated with symptomatic and asymptomatic ICH after t-PA therapy.

摘要

背景与目的

静脉注射组织型纤溶酶原激活剂(t-PA)可改善急性缺血性脑卒中患者的临床预后。t-PA治疗最重要的并发症是脑出血(ICH)。本研究的目的是通过系列MRI研究确定t-PA治疗后有症状和无症状ICH的独立预测因素。

方法

对卒中发作3小时内接受t-PA治疗的连续性前循环缺血性脑卒中患者进行前瞻性研究。为确定闭塞动脉再通情况及ICH的存在,在t-PA溶栓前、溶栓后1小时、24小时和5 - 7天进行MRI检查,包括弥散加权成像(DWI)、T2*加权成像和磁共振血管造影(MRA)。使用多因素逻辑回归分析确定ICH的独立预测因素。

结果

共纳入41例患者(男性21例,女性20例;平均年龄73.2±10.7岁),T2*加权成像观察到19例ICH(1例有症状,18例无症状)。初始MRA显示31例患者(75.6%)脑动脉闭塞,其中t-PA治疗后1小时、24小时和5 - 7天的随访MRA显示再通率分别为48.4%、80.0%和90.0%。t-PA治疗后1小时内ICH组和无ICH组的再通频率无差异,但t-PA治疗后1至24小时内ICH组的再通频率高于无ICH组(50.0% vs. 4.5%,P = 0.001)。ICH组房颤(AF)发生率高于无ICH组(78.9% vs. 27.3%,P = 0.001)。与无ICH组相比,ICH组美国国立卫生研究院卒中量表(NIHSS)评分更高(16.4±5.7 vs. 11.5±6.5,P = 0.011),DWI的脑缺血半暗带评分(ASPECTS-DWI)值更低(正常DWI的ASPECTS-DWI值为11分,7.3±2.4 vs. 8.9±1.9,P = 0.019)。多因素逻辑回归分析表明,t-PA输注结束后1至24小时内出现再通(比值比:20.2;95%置信区间:1.0 - 340.9;P = 0.037)是ICH的唯一独立预测因素。

结论

t-PA输注后1至24小时而非1小时内闭塞动脉的再通与t-PA治疗后有症状和无症状ICH独立相关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验